Paper14970397
Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles.
Chan J and 4 others. RNA, 2004. Cited by 51 papers, by iCite.
Cite this record
ConductScience Library. Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles. Papers, record 14970397. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14970397
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Eukaryotic Cells | Major topic |
| Protein Biosynthesis | Major topic |
| Protein Synthesis Inhibitors | Major topic |
| Algorithms | |
| Benzofurans | |
| Diterpenes | |
| Dose-Response Relationship, Drug | |
| Genes, Reporter | |
| Glycosides | |
| HeLa Cells | |
| Humans | |
| Polyribosomes | |
| Sesquiterpenes | |
| Spiro Compounds |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7619818 | Mechanism of protein synthesis inhibition by didemnin B in vitro. | Biochemistry | 1995 | https://conductscience.org/library/papers/7619818 | PubMed |
| 2 | 2720652 | Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide. | Cancer Res | 1989 | https://conductscience.org/library/papers/2720652 | PubMed |
| 3 | 3698162 | Disposition and metabolism of the antitumor glycoside phyllanthoside in mouse and beagle dog. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3698162 | PubMed |
| 4 | 2204626 | Nucleotide sequence, expression, and properties of luciferase coded by lux genes from a terrestrial bacterium. | J Biol Chem | 1990 | https://conductscience.org/library/papers/2204626 | PubMed |
| 5 | 221915 | Codon-anticodon interaction at the ribosomal P (peptidyl-tRNA)site. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/221915 | PubMed |
| 6 | 6197992 | Inhibition of protein synthesis in CHO cells by actinomycin D: lesion occurs after 40S initiation complex formation. | Biochemistry | 1983 | https://conductscience.org/library/papers/6197992 | PubMed |
| 7 | 12403465 | Inhibition of protein synthesis by aminoglycoside-arginine conjugates. | RNA | 2002 | https://conductscience.org/library/papers/12403465 | PubMed |
| 8 | 5965321 | Synthesis of ribonucleic acid in L cells during inhibition of protein synthesis by cycloheximide. | Mol Pharmacol | 1966 | https://conductscience.org/library/papers/5965321 | PubMed |
| 9 | 7741767 | Site of action of two novel pyrimidine biosynthesis inhibitors accurately predicted by the compare program. | Biochem Pharmacol | 1995 | https://conductscience.org/library/papers/7741767 | PubMed |
| 10 | 5707707 | Guanosine triphosphate dependent enzymic binding of aminoacyl transfer ribonucleic acid to yeast ribosomes. | Eur J Biochem | 1968 | https://conductscience.org/library/papers/5707707 | PubMed |
| 11 | 4343427 | Mode of action of tylocrebrine: effects on protein and nucleic acid synthesis. | Mol Pharmacol | 1972 | https://conductscience.org/library/papers/4343427 | PubMed |
| 12 | 11824527 | An antiproliferative norditerpene dilactone, Nagilactone C, from Podocarpus neriifolius. | Phytomedicine | 2001 | https://conductscience.org/library/papers/11824527 | PubMed |
| 13 | 1175595 | Effects of ricin on the ribosomal sites involved in the interaction of the elongation factors. | Eur J Biochem | 1975 | https://conductscience.org/library/papers/1175595 | PubMed |
| 14 | 1240811 | Antitumor activity of nagilactones. | Gan | 1975 | https://conductscience.org/library/papers/1240811 | PubMed |
| 15 | 9988267 | The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. | Nat Genet | 1999 | https://conductscience.org/library/papers/9988267 | PubMed |
| 16 | 11953842 | Translation initiation and its deregulation during tumorigenesis. | Br J Cancer | 2002 | https://conductscience.org/library/papers/11953842 | PubMed |
| 17 | 5907359 | Inhibitory effects of acetoxycycloheximide, puromycin, and pactamycin upon synthesis of protein and DNA in asynchronous populations of HeLa cells. | Mol Pharmacol | 1966 | https://conductscience.org/library/papers/5907359 | PubMed |
| 18 | 10608919 | Antitumor compounds from tunicates. | Med Res Rev | 2000 | https://conductscience.org/library/papers/10608919 | PubMed |
| 19 | 10585489 | Translational regulation of ribonucleotide reductase by eukaryotic initiation factor 4E links protein synthesis to the control of DNA replication. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10585489 | PubMed |
| 20 | 11050335 | Internal ribosome initiation of translation and the control of cell death. | Trends Genet | 2000 | https://conductscience.org/library/papers/11050335 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37860121 | YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37860121 | PubMed |
| 37537169 | Molecular basis of the pleiotropic effects by the antibiotic amikacin on the ribosome. | Nat Commun | 2023 | https://conductscience.org/library/papers/37537169 | PubMed |
| 36982256 | Anticancer Small-Molecule Agents Targeting Eukaryotic Elongation Factor 1A: State of the Art. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982256 | PubMed |
| 35589706 | Ribosome inhibition by C9ORF72-ALS/FTD-associated poly-PR and poly-GR proteins revealed by cryo-EM. | Nat Commun | 2022 | https://conductscience.org/library/papers/35589706 | PubMed |
| 35525914 | Pharmacogenomics of in vitro response of the NCI-60 cancer cell line panel to Indian natural products. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35525914 | PubMed |
| 35184897 | Spatiotemporally resolved protein synthesis as a molecular framework for memory consolidation. | Trends Neurosci | 2022 | https://conductscience.org/library/papers/35184897 | PubMed |
| 34503202 | Inhibition of the Eukaryotic 80S Ribosome as a Potential Anticancer Therapy: A Structural Perspective. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34503202 | PubMed |
| 34251165 | Identifying the Cellular Target of Cordyheptapeptide A and Synthetic Derivatives. | ACS Chem Biol | 2021 | https://conductscience.org/library/papers/34251165 | PubMed |
| 33996904 | Hiding in Plain Sight: Formation and Function of Stress Granules During Microbial Infection of Mammalian Cells. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/33996904 | PubMed |
| 33862007 | The nucleolus as a polarized coaxial cable in which the rDNA axis is surrounded by dynamic subunit-specific phases. | Curr Biol | 2021 | https://conductscience.org/library/papers/33862007 | PubMed |
| 33289002 | Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19. | Heliyon | 2020 | https://conductscience.org/library/papers/33289002 | PubMed |
| 33280581 | A Quick Guide to Small-Molecule Inhibitors of Eukaryotic Protein Synthesis. | Biochemistry (Mosc) | 2020 | https://conductscience.org/library/papers/33280581 | PubMed |
| 33034879 | Anticancer Activities and Mechanism of Action of Nagilactones, a Group of Terpenoid Lactones Isolated from Podocarpus Species. | Nat Prod Bioprospect | 2020 | https://conductscience.org/library/papers/33034879 | PubMed |
| 30541569 | The Plasmodium falciparum cytoplasmic translation apparatus: a promising therapeutic target not yet exploited by clinically approved anti-malarials. | Malar J | 2018 | https://conductscience.org/library/papers/30541569 | PubMed |
| 28457705 | Inhibition of Eukaryotic Translation by the Antitumor Natural Product Agelastatin A. | Cell Chem Biol | 2017 | https://conductscience.org/library/papers/28457705 | PubMed |
| 28322844 | A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis. | Eur J Pharmacol | 2017 | https://conductscience.org/library/papers/28322844 | PubMed |
| 27592390 | Design of nucleotide-mimetic and non-nucleotide inhibitors of the translation initiation factor eIF4E: Synthesis, structural and functional characterisation. | Eur J Med Chem | 2016 | https://conductscience.org/library/papers/27592390 | PubMed |
| 27528614 | Differences and Similarities in TRAIL- and Tumor Necrosis Factor-Mediated Necroptotic Signaling in Cancer Cells. | Mol Cell Biol | 2016 | https://conductscience.org/library/papers/27528614 | PubMed |
| 25209664 | Structural basis for the inhibition of the eukaryotic ribosome. | Nature | 2014 | https://conductscience.org/library/papers/25209664 | PubMed |
| 24974795 | Translational control of mGluR-dependent long-term depression and object-place learning by eIF2α. | Nat Neurosci | 2014 | https://conductscience.org/library/papers/24974795 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14970397
GET https://conductscience.org/api/papers/v1/14970397/references?page=2